Glucocorticoid-induced osteoporosis: pathogenesis and management

BP Lukert, LG Raisz - Annals of internal medicine, 1990 - acpjournals.org
Purpose: To review the clinical picture, pathogenesis, and management of glucocorticoid-
induced osteoporosis. Data Identification: Studies published since 1970 were identified from …

Hypothalamic amenorrhea and the long-term health consequences

CL Shufelt, T Torbati, E Dutra - Seminars in reproductive …, 2017 - thieme-connect.com
The menstrual cycle is a reproductive vital sign and provides insight into hormonal
imbalance as well as pregnancy. The significance of estrogen, however, extends beyond …

Alendronate for the prevention and treatment of glucocorticoid-induced osteoporosis

KG Saag, R Emkey, TJ Schnitzer… - … England Journal of …, 1998 - Mass Medical Soc
Background Osteoporosis is a common complication of long-term glucocorticoid therapy for
which there is no well-proved preventive or restorative treatment. Methods We carried out …

Guidelines for osteoporosis in coeliac disease and inflammatory bowel disease

EM Scott, I Gaywood, BB Scott - Gut, 2000 - gut.bmj.com
Osteoporotic fractures are a major public health problem. It has been estimated that in the
USA the remaining lifetime fracture risk at the age of 50 years is 40% for white women and …

Mechanisms of glucocorticoid action in bone

E Canalis, AM Delany - Annals of the New York Academy of …, 2002 - Wiley Online Library
Glucocorticoids cause profound effects on bone cell replication, differentiation, and function.
Glucocorticoids increase bone resorption by stimulating osteoclastogenesis by increasing …

AGA technical review on osteoporosis in gastrointestinal diseases

CN Bernstein, WD Leslie, MS Leboff - Gastroenterology, 2003 - Elsevier
Osteoporosis is increasingly recognized as a source of significant disability, an awareness
that has prompted clinicians to actively pursue the diagnosis among high-risk patients …

Effects of risedronate treatment on bone density and vertebral fracture in patients on corticosteroid therapy

S Wallach, S Cohen, DM Reid, RA Hughes… - Calcified Tissue …, 2000 - Springer
Men and women (n= 518) receiving moderate-to-high doses of corticosteroids were enrolled
in two studies with similar protocols and randomly assigned to receive either placebo or …

[PDF][PDF] Clinical review 83: Mechanisms of glucocorticoid action in bone: implications to glucocorticoid-induced osteoporosis

E Canalis - The Journal of clinical endocrinology & metabolism, 1996 - oxfordjournals.org
Bone remodeling is regulated by systemic hormones and locally produced factors acting in
concert to maintain bone mass (1). In the adult skeleton, bone remodeling is a tightly …

Oral supplementation with 25(OH)D3 versus vitamin D3: Effects on 25(OH)D levels, lower extremity function, blood pressure, and markers of innate immunity

HA Bischoff‐Ferrari, B Dawson‐Hughes… - Journal of Bone and …, 2012 - academic.oup.com
To test the effect of 25 (OH) D3 (HyD) compared to vitamin D3 on serum 25‐hydroxyvitamin
D levels (25 (OH) D), lower extremity function, blood pressure, and markers of innate …

Oral glucocorticoid use is associated with an increased risk of fracture

M Steinbuch, TE Youket, S Cohen - Osteoporosis international, 2004 - Springer
Oral glucocorticoids (GCs) are widely used and despite their adverse effects on bone
mineral density, the risk of sustaining osteoporotic fractures is not well addressed. The …